Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective lifted by equities research analysts at Needham & Company LLC from $133.00 to $153.00 in a report released on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback